Industry Expertise

The Wise Pivot

Operational improvement efforts are often complicated by the increasing complexity of managing diversification and specialization within a changing healthcare landscape. DMO has decades of experience in all aspects of pharmaceutical and biologic operations, allowing us to help clients identify opportunities for revenue enhancement, efficiency improvement, and cost reduction throughout the entire production cycle. We have served within these industries, with operations engagements allowing us a detailed understanding of industry trends and challenges.

Pharma has strong correlations to time and money which is now being driven by the co-existence of new technologies in AI and Digital platforms and its integration into the workforce and patient management

Rules and Regulations play a large role in pharma industry than biotech. Due to drug pricing and new technologies that will complicate the decision-making spheres of technology driven NDAs.

Like biotech, pharma predominately utilizes a traditional hierarchy (waterfall) approach causing constrictions on workforce partnering, executive diversity, leadership building and continuous improvement..

Global competition will require pharma to improve, patient engagement and customer service. Moving away from a one size fits all portfolio of treatments. In addition to managing the convergence of health equity and the disruption of a growing pool of data driven tools that will impact market flux and external partner alliances.

SpotlightNewsletter

Learn DMO’s Innovative Strategic and Communication Practices and How You Can Use Them to Improve Your Business.

A Niche Life Science Consultancy

contact

New York City
United States
+646.868.5378
info@dmoconsultingfirm.com

T I TALK TO US N D N M G S O U C L O